Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Capital Expenditures (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Capital Expenditures for 4 consecutive years, with $53.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 48.04% year-over-year to $53.0 million, compared with a TTM value of $164.0 million through Dec 2025, down 59.1%, and an annual FY2025 reading of $164.0 million, down 59.1% over the prior year.
  • Capital Expenditures was $53.0 million for Q4 2025 at GE HealthCare Technologies, up from $21.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $156.0 million in Q2 2024 and bottomed at -$97.0 million in Q4 2022.
  • Average Capital Expenditures over 4 years is $68.0 million, with a median of $77.0 million recorded in 2022.
  • The sharpest move saw Capital Expenditures surged 196.91% in 2023, then crashed 97.44% in 2025.
  • Year by year, Capital Expenditures stood at -$97.0 million in 2022, then soared by 196.91% to $94.0 million in 2023, then rose by 8.51% to $102.0 million in 2024, then tumbled by 48.04% to $53.0 million in 2025.
  • Business Quant data shows Capital Expenditures for GEHC at $53.0 million in Q4 2025, $21.0 million in Q3 2025, and $4.0 million in Q2 2025.